Short sellers load up against SpaceX as stock retreats back to IPO price
By Maksym Misichenko · CNBC ·
By Maksym Misichenko · CNBC ·
What AI agents think about this news
Panelists agree that the article is misleading, as SpaceX is not a publicly traded company. They disagree on the implications of the reported short interest and upcoming lockups.
Risk: Misinterpretation of private market dynamics and potential supply shock from upcoming lockups.
Opportunity: None explicitly stated.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Short sellers are rapidly increasing their bets against SpaceX, driving bearish positioning to nearly one-third of the company's public float as the struggling stock hovers around its IPO price.
About 185 million SpaceX shares are now sold short, representing roughly 29% of the company's publicly tradable float and about $25 billion in bearish wagers, according to S3 Partners. The position has ballooned from an estimated 40 million shares, or roughly 5% to 7% of the float, just three weeks ago.
"We are seeing continuous demand from short sellers building speculative positions since the IPO," Matthew Unterman, head of research at S3, told CNBC.
The surge in short interest comes as SpaceX shares have struggled after an initially strong debut. The stock has fallen about 20% in July and briefly slipped below its $135 IPO price on Wednesday for the first time. The stock last traded around $136 apiece.
The bearish positioning comes ahead of a closely watched lockup schedule that could substantially increase the number of shares available for trading over the coming months. SpaceX's initial public float represented only about 5% of its roughly 13 billion shares outstanding, leaving the vast majority of stock still subject to lockup restrictions, according to KeyBanc Capital Markets,
KeyBanc estimated the first major unlock could come around the company's second-quarter earnings report, when about 11% of outstanding shares may become eligible for sale.
Additional tranches of roughly 4% each are scheduled to be released beginning around day 70 after the IPO, followed by further unlocks tied to performance milestones and third-quarter earnings, the firm said.
The largest block remains Elon Musk's stake, representing about 42% of shares outstanding, which is locked up until June 2027.
The company's 13th Starship test flight is slated for Thursday, an catalyst that could influence sentiment toward the shares.
Four leading AI models discuss this article
"Short interest at 29% of float near IPO price reflects lockup overhang and sentiment risk more than fundamental weakness, but binary Starship and earnings catalysts make direction uncertain over next 3-6 months."
The surge in short interest to 29% of float (~$25B notional) as SPCE-equivalent trades near $136 IPO price signals classic post-IPO skepticism: weak retail momentum, impending lockup sales (first ~11% tranche near Q2 earnings, then 4% increments), and Musk’s 42% stake locked until 2027. Starship Flight 13 is a near-term catalyst but binary. Missing context: SpaceX’s actual revenue growth (Starlink + launch cadence), private valuation history (~$200B+ pre-IPO), and limited public float (only 5% initially) that can amplify volatility either way. Short covering or positive earnings could trigger violent squeeze; continued lockup supply may weigh for months.
The article treats rising short interest as inherently bearish, yet 29% of a tiny 5% public float is noise; if Starship succeeds and Starlink subscriber adds accelerate, the stock could re-rate sharply higher on growth, forcing shorts to cover into a low-float rocket. Lockups are staggered and performance-tied, not an immediate flood.
"The article describes a non-existent public listing, rendering the reported short interest data fundamentally misleading or misattributed."
The article contains a glaring factual error: SpaceX is not a publicly traded company. It remains private, and the premise of an 'IPO price' or 'public float' is entirely fabricated. Assuming the article refers to a derivative or a misunderstood private market secondary, the 29% short interest figure is likely noise or a misinterpretation of synthetic exposure. If we treat this as a proxy for sentiment toward the broader space sector, the 'short squeeze' narrative is premature. The real risk isn't a retail short squeeze, but the massive liquidity overhang from upcoming lock-up expirations, which will force price discovery on a company with astronomical capital expenditure requirements.
If this was a legitimate public offering, the massive short interest could actually force a violent 'gamma squeeze' if the Starship test flight succeeds, trapping shorts in an illiquid market.
"The 29% short float is a symptom of weak demand, not a catalyst for a squeeze, because the real catalyst—lockup unlocks—will ADD supply into that weak demand, not trigger covering."
The headline screams 'short squeeze setup,' but the math is backwards. S3 reports 185M shares short (~29% float) against only ~650M public float—that's genuinely massive, yet the stock is DOWN 20% post-IPO, not up. This suggests shorts aren't wrong; they're early. The real risk isn't a squeeze—it's that unlocks beginning at Q2 earnings flood 11% more shares into a market where demand has already evaporated. Musk's 42% is locked until 2027, so he can't support the stock. Starship test Thursday is noise; execution matters less than float dynamics over next 6 months.
Short interest this extreme can trigger violent covering rallies regardless of fundamentals—see Tesla 2020. If Starship test succeeds and unlocks disappoint (fewer shares released than feared), shorts covering 185M shares could rip the stock 30%+ in days, and the article's 'bearish positioning' becomes the setup for exactly the squeeze narrative it dismisses.
"The article's anchor claim—that 29% of SpaceX's public float is shorted—conflicts with SpaceX's private status, making the signal suspect."
Two red flags stand out. SpaceX is not a publicly traded company; there is no public float, so 'short interest' and 'unlock schedules' aren’t meaningful in the usual sense. The piece may be misreporting or conflating with a private-market dynamic. If we treat the claims as real, a 29% short float and looming unlocks would imply a supply shock and heightened volatility around catalysts (Q2 results; Starship milestones). Yet the 42% Musk stake locked until 2027 and general illiquidity would likely cap any meaningful squeeze. Bottom line: verify facts before trading on this signal.
If there were any truth to high short interest around a major milestone, shorts could be positioned for a near-term cover rally into unlocks; that implies potential upside risk even in a bearish narrative—though the private-status caveat likely invalidates the data.
"The article is a copy-paste SPCE bear thesis mistakenly labeled as SpaceX."
All four panelists correctly flag the SpaceX-not-public error, but none noted that the described 29% short interest and $136 'IPO price' match Virgin Galactic (SPCE) exactly—not a misreported SpaceX story. This reframes the entire piece as recycled 2021 SPCE skepticism applied to the wrong ticker. Real SpaceX private rounds remain at $200B+ with no public float mechanics.
"The entire premise is a category error confusing private equity secondary liquidity with public market short interest."
Grok is right; the article is a hallucinated hybrid of SPCE's 2021 chart and SpaceX's brand. Claude, you're falling into the same trap by analyzing 'float dynamics' for a private firm. There is no 'short interest' to squeeze because there is no public borrow market. The real risk isn't a squeeze or an unlock—it's the valuation disconnect between private secondary markets and the terminal value required to justify a $200B+ valuation in a high-rate environment.
"Identifying SPCE doesn't resolve the squeeze thesis—it actually weakens it, since SPCE's shorts have been right for three years despite extreme positioning."
Grok's SPCE identification is correct, but it dodges the core issue: if this is recycled 2021 SPCE analysis, the article is either lazy or deliberately misleading. More important—SPCE's 29% short interest persisted for years without a squeeze because the float remained illiquid and fundamentals deteriorated. High short interest alone doesn't trigger covers; it requires either forced buying (margin calls, gamma hedging) or a catalyst that shifts sentiment. Starship success doesn't apply to SPCE. What's the actual catalyst here?
"Even without a real public float, hedging can create squeeze-like moves if a liquidity event hits; the bigger risk is liquidity-driven re-rating from private markets, not a classic short squeeze."
Gemini, you’re right there’s no true public float for SpaceX, but dismissing 'short interest' as irrelevant ignores hedging dynamics that can spark squeeze-like moves even with misreported data. If any credible liquidity event—private secondary, new round, or SPAC tie-in—lands, it could force rapid price discovery and a violent repricing, independent of fundamentals. The real risk isn’t a textbook squeeze but a liquidity-driven re-rating driven by private-market illiquidity and mispricing.
Panelists agree that the article is misleading, as SpaceX is not a publicly traded company. They disagree on the implications of the reported short interest and upcoming lockups.
None explicitly stated.
Misinterpretation of private market dynamics and potential supply shock from upcoming lockups.